Researcher.Life Logo

Cancer Biology and Medicine : Impact Factor & More

eISSN: 2095-3941pISSN: 2095-3941
JournalOpen Access

Key Metrics

CiteScore
6.5
SNIP
1.13
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Biology and Medicine

Cancer Biology and Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher CHINA ANTI-CANCER ASSOC
Language English
Frequency Quarterly
Article Processing ChargesUSD 1500
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2012
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 12
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Cancer Biology and Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Biology and Medicine

Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units.
  • 29 Jan 2026
  • Cancer biology & medicine
Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1/PD-L1 therapy.
  • 29 Jan 2026
  • Cancer biology & medicine
Innovative cross-intervention: copper ions and metabolic pathways in cancer therapy.
  • 20 Jan 2026
  • Cancer biology & medicine
SPRED2 suppresses the stemness of hepatocellular carcinoma through the p53/miR-506-3p/KLF4 pathway.
  • 20 Jan 2026
  • Cancer biology & medicine
Temporal radiomics for non-invasive preoperative prediction of pathologic complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
  • 14 Jan 2026
  • Cancer biology & medicine
Migration and invasion inhibitory protein inhibits M2 macrophage polarization to suppress colorectal cancer progression through the STING-NFκB2-IL10 axis.
  • 14 Jan 2026
  • Cancer biology & medicine
Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units.
  • 29 Jan 2026
  • Cancer biology & medicine
Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1/PD-L1 therapy.
  • 29 Jan 2026
  • Cancer biology & medicine
Innovative cross-intervention: copper ions and metabolic pathways in cancer therapy.
  • 20 Jan 2026
  • Cancer biology & medicine
SPRED2 suppresses the stemness of hepatocellular carcinoma through the p53/miR-506-3p/KLF4 pathway.
  • 20 Jan 2026
  • Cancer biology & medicine
Temporal radiomics for non-invasive preoperative prediction of pathologic complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
  • 14 Jan 2026
  • Cancer biology & medicine
Migration and invasion inhibitory protein inhibits M2 macrophage polarization to suppress colorectal cancer progression through the STING-NFκB2-IL10 axis.
  • 14 Jan 2026
  • Cancer biology & medicine

FAQs on Cancer Biology and Medicine